Pharmafile Logo

Mastering Outcome vs. Process Control in Remote Work – Building Company Culture Virtually

Struggling to manage your remote pharma teams effectively? Discover the power of outcome control. Learn how trusting your team to achieve results, their way, can lead to greater productivity and a more positive work culture. Stop micromanaging, start empowering!

In the seventh video of our series on creating company culture in a virtual environment, explore the essential leadership shift from process control to outcome control in remote work settings. Learn how this approach can enhance productivity and employee empowerment.

7. Learn the Difference Between Outcome Control vs. Process Control
In the remote work era, the traditional concerns about productivity have shifted as leaders gain more experience and confidence in their teams. This is why it’s crucial for leaders to focus on outcome control rather than process control. With the blending of work life and home life, especially evident in 2020, employees may need to juggle home-schooling children, sharing office spaces with partners, and more. By prioritizing outcomes over the specifics of day-to-day processes, leaders can trust their teams to achieve their goals in the way that best suits their unique circumstances. This shift not only empowers employees but also streamlines productivity, making the transition to remote work more sustainable and effective for everyone involved.

For deeper insights and to learn from our experiences, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

Enhance your virtual meeting strategies with Impetus Digital:

Stay connected for more tips on remote work and trending Pharma Topics:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Reimagining the Patient Journey

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...